Our data demonstrate that S100A4 drives the invasive capacity of lung cancer cells, affects the NF-κB pathway, and acts as an essential component of TNF-α-induced and NF-κB-dependent MMP9 expression. The gene discussed is TNF; the disease is lung cancer.